SINGLE-CELL CHEMICAL TRANSCRIPTOMIC DISSECTION OF AN ESSENTIAL TRANSCRIPTION FACTOR NETWORK
SINGLE-CELL CHEMICAL TRANSCRIPTOMIC DISSECTION OF AN ESSENTIAL TRANSCRIPTION FACTOR NETWORK
批准号:
10514497
负责人:
Vijay Ramani
金额:
$145.35万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-11-04 至 2024-08-31
中文摘要
项目摘要/摘要
英文摘要
PROJECT SUMMARY / ABSTRACT
Basic helix-loop-helix leucine zipper transcription factors (TFs) in the extended MYC network play essential
roles regulating cellular growth, differentiation, and homeostasis. Seminal studies have implicated MYC
and its interacting network of TFs as drivers of proliferation and metabolism in development and cancer, but
how dosage of these factors encodes transcriptional state remains contentious. Here, I propose a novel
chemical genomic framework to systematically determine how TF dosage, transcriptional output, and
cellular state are linked. I will combine our recently published massively multiplex single-cell RNA-seq
screening method (sci-Plex) with chemical genetic degradation of protein targets to examine how
embryonic stem cells are transcriptionally reprogrammed following dosed degradation of TFs. I will then
employ state-of-the-art computational tools to quantify the cellular state trajectories encoded by specific
dosages. Finally, I will leverage this single-cell ‘perturbation atlas’ to support genomic mapping experiments
to understand how reduced dosage of these factors in vivo leads to physical redistribution across the
genome. These studies will i.) illuminate mechanisms by which TF dosages encode transcriptional output,
ii.) elucidate how intracellular concentrations of interacting TFs maintain chromatin, transcriptional, and
cellular states, and iii.) provide mechanistic insight into how a transcription factor network interacts with the
epigenome to regulate mammalian pluripotency. More generally, these approaches have the potential to
address long-standing gene regulatory questions of how protein dosage controls cellular state in both
health and in cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SINGLE-CELL CHEMICAL TRANSCRIPTOMIC DISSECTION OF AN ESSENTIAL TRANSCRIPTION FACTOR NETWORK
-
批准号:10244771
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Vijay Ramani
-
依托单位:
国内基金
海外基金
登录
查看更多内容
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
-
批准号:QN25H220002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:顾媛
-
依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王锐智
-
依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造
血干细胞生成中的作用及机制研究
-
批准号:TGY24H080011
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李鸿鹄
-
依托单位:
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
-
批准号:82305053
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王丽明
-
依托单位:
面向Cell-Free网络的协同虚拟化与动态传输
-
批准号:62371367
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:陈健
-
依托单位:
Cell-in-cell促进曲妥珠单抗耐药乳腺癌细胞转移的作用与分子机制
-
批准号:82373069
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:何美芳
-
依托单位:
基于Multi-Pass Cell的高功率皮秒激光脉冲非线性压缩关键技术研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:宋贾俊
-
依托单位:
基于定点突变膜受体Cell-free合成生物色谱新方法的PDGFRβ抑制剂筛选和结合位点分析
-
批准号:82273886
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:原永芳
-
依托单位:
FLRT3抑制异质性cell-in-cell结构形成机制及细胞免疫调节作用研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:51万元
-
批准年份:2022
-
负责人:黄红艳
-
依托单位:
基于Cell-SELEX 的磁珠富集技术与LAMP 联合构建的梅毒螺旋体核酸检测方法及其临床应用
-
批准号:2021JJ30609
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:肖勇健
-
依托单位: